Absence of association between codon 129 and 219 polymorphisms of the prion protein gene and vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 2, 2007, Pages 86-90

  Jeong, Byung Hoon ^a   Na, Hae Ri ^b   Bae, Jae Chun ^a   Lee, Kyung Hee ^a   Lee, Yun Jung ^a   Kim, Nam Ho ^a   Song, Joon Ho ^a   Carp, Richard I ^c   Kim, Yong Sun ^a  

^a Hallym University   (South Korea)

^b Bobath Memorial Hospital   (South Korea)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Population genetics, Korea; Prion protein gene; Single nucleotide polymorphism; Vascular dementia

Indexed keywords

PRION PROTEIN;

AGED; ARTICLE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ALLELES; CODON; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; MALE; MIDDLE AGED; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRIONS; RISK FACTORS; STATISTICS;

EID: 34447637094     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103913     Document Type: Article

References (41)

1. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D: Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy: the ILSA study. J Am Geriatr Soc 2002;50:41-48.
2. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF: Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31:1487-1493.
3. Yi S, Suh C, Park Y, Park J: Causative diseases of 108 dementia patients. Kor J Neurol 1988;6:234-239.
4. Woo JI, Lee JH, Yoo KY, Kim CY, Kim YI, Shin YS: Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998;46:983-987.
5. Urakami K, Adachi Y, Wakutani Y, Isoe K, Ji Y, Takahahi K, Nakashima K: Epidemiologic and genetic studies of dementia of the Alzheimer type in Japan. Dement Geriatr Cogn Disord 1998;9:294-298.
6. Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E, EUROCJD: Genetic prion disease: the EUROCJD experience. Hum Genet 2005;118:166-174.
7. Mead S: Prion disease genetics. Eur J Hum Genet 2006;14:273-281.
8. Jeong BH, Lee KH, Kim NH, Jin JK, Kim JI, Carp RI, Kim YS: Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics 2005;6:229-232.
9. Palmer MS, Dryden AJ, Hughes JT, Collinge J: Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-342.
10. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T: Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1998;43:826-828.
11. Del Bo R, Comi GP, Giorda R, Crimi M, Locatelli F, Martinelli-Boneschi F, Pozzoli U, Castelli E, Bresolin N, Scarlato G: The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects. J Neurol 2003;250:688-692.
12. Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, Galbiati S, Virgilio R, Galimberti D, Ferrarese C, Scarpini E, Bresolin N, Comi GP: Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a metaanalysis. Neurobiol Aging 2006;27:770.e1-770.e5.
13. Lampe J, Kitzler H, Walter MC, Lochmuller H, Reichmann H: Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis. Lancet 1999;353:465-466.
14. Li X, Rowland LP, Mitsumoto H, Przedborski S, Bird TD, Schellenberg GD, Peskind E, Johnson N, Siddique T, Mesulam MM, Weintraub S, Mastrianni JA: Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol 2005;58:858-864.
15. Scholz SW, Xiromerisiou G, Fung HC, Eerola J, Hellstrom O, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Fernandez HH, Mandel R, Okun MS, Gwinn-Hardy K, Singleton AB: The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations. Neurosci Lett 2006;395:227-229.
16. Tsai MT, Su YC, Chen YH, Chen CH: Lack of evidence to support the association of the human prion gene with schizophrenia. Mol Psychiatry 2001;6:74-78.
17. Croes EA, Dermaut B, Houwing-Duistermaat JJ, Van den Broeck M, Cruts M, Breteler MM, Hofman A, van Broeckhoven C, van Duijn CM: Early cognitive decline is associated with prion protein codon 129 polymorphism. Ann Neurol 2003;54:275-276.
18. Papassotiropoulos A, Wollmer MA, Aguzzi A, Hock C, Nitsch RM, de Quervain DJ: The prion gene is associated with human longterm memory. Hum Mol Genet 2005;14:2241-2246.
19. Rujescu D, Hartmann AM, Gonnermann C, Moller HJ, Giegling I: M129V variation in the prion protein may influence cognitive performance. Mol Psychiatry 2003;8:937-941.
20. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 (DSM-IV). Washington, American Psychiatric Association, 1994, pp 143-147.
21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
22. Ahn K, Kim E, Kwon YA, Kim DK, Lee JE, Jo SA: No association of prion protein gene polymorphisms with Alzheimer's disease in Korean population. Exp Mol Med. 2006;38:727-731.
23. Kim Y, Kim JH, Nam YJ, Kim YJ, Yu KH, Lee BC, Lee C: Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia. Neurosci Lett 2006;401:276-279.
24. 1 confers risk of ischemic stroke and vascular dementia. Stroke 2006;37:2843-2845.
25. Kim Y, Nam YJ, Lee C: Analysis of the SREBF2 gene as a genetic risk factor for vascular dementia. Am J Med Genet B Neuropsychiatr Genet 2005;139:19-22.
26. Kim Y, Nam YJ, Lee C: Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia. Am J Med Genet B Neuropsychiatr Genet 2006;141:332-335.
27. 1 and AD, vascular dementia, and stroke. Neurology 2004;63:2255-2260.
28. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor αand risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001;357:436-439.
29. Pola R, Flex A, Gaetani E, Papaleo P, De Martini D, Gerardino L, Serricchio M, Pola P, Bernabei R: Association between intercellular adhesion molecule-1 E/K gene polymorphism and probable vascular dementia in humans. Neurosci Lett 2002;326:171-174.
30. Pola R, Gaetani E, Flex A, Aloi F, Papaleo P, Gerardino L, De Martini D, Flore R, Pola P, Bernabei R: -174 G/C interleukin-6 gene polymorphism and increased risk of multiinfarct dementia: a case-control study. Exp Gerontol 2002;37:949-955.
31. Combarros O, Sanchez-Guerra M, Llorca J, Alvarez-Arcaya A, Berciano J, Pena N, Fernandez-Viadero C: Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD. Neurology 2000;55:593-595.
32. Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, van Duijn CM, Van Broeckhoven C: PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease. Ann Neurol 2003;53:409-412.
33. Gacia M, Safranow K, Styczynska M, Jakubowska K, Peplonska B, Chodakowska-Zebrowska M, Przekop I, Slowik A, Golanska E, Hulas-Bigoszewska K, Chlubek D, Religa D, Zekanowski C, Barcikowska M: Prion protein gene M129 allele is a risk factor for Alzheimer's disease. J Neural Transm 2006;113:1747-1751.
34. Ohkubo T, Sakasegawa Y, Asada T, Kinoshita T, Goto Y, Kimura H, Mizusawa H, Hachiya NS, Kaneko K: Absence of association between codon 129/219 polymorphisms of the prion protein gene and Alzheimer's disease in Japan. Ann Neurol 2003;54:553-554.
35. Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Muller U, Forstl H, Illig T, Kretzschmar H, Kurz A: Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 2004;63:364-366.
36. Rohrer JD, Mead S, Omar R, Poulter M, Warren JD, Collinge J, Rossor MN: Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes. Ann Neurol 2006;60:616.
37. Jeong BH, Nam JH, Lee YJ, Lee KH, Jang MK, Carp RI, Lee HD, Ju YR, Jo SA, Park KY, Kim YS: Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet 2004;49:319-324.
38. Jeong BH, Kim NH, Choi EK, Lee C, Song YH, Kim JI, Carp RI, Kim YS: Polymorphism at 3′ UTR + 28 of the prion-like protein gene is associated with sporadic Creutzfeldt-Jakob disease. Eur J Hum Genet 2005;13:1094-1097.
39. Jeong BH, Kim NH, Kim JI, Carp RI, Kim YS: Polymorphisms at codons 56 and 174 of the prion-like protein gene (PRND) are not associated with sporadic Creutzfeldt-Jakob disease. J Hum Genet 2005;50:311-314.
40. Peoc'h K, Guerin C, Brandel JP, Launay JM, Laplanche JL: First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett 2000;286:144-148.
41. Schroder B, Franz B, Hempfling P, Selbert M, Jurgens T, Kretzschmar HA, Bodemer M, Poser S, Zerr I: Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders. Hum Genet 2001;109:319-325.